Sample 13
Homo sapiens
Protocols: Whole blood was taken at each participant visit, each participant had had at least two PAXgene tubes of whole blood collected for RNA extraction. All patients were given etanercept subcutaneous administration 25mg twice weekly (administered either as 25mg twice weekly or 50mg once weekly). miRNA were extracted from blood using miRNeasy blood kits according to manufacturers' protocol. RNA was quantified and quality controlled (assuring a RIN>8) using the Agilent RNA 6000 Nano Kit (Agilent Technologies, Waldbronn, Germany) using the manufacturer's protocol. TruSeq Small RNA library preparation (Illumina)
ENA-FIRST-PUBLIC
2018-09-21T17:02:08Z
ENA-LAST-UPDATE
2018-09-11T13:57:22Z
External Id
SAMEA4893584
INSDC center name
QMUL
INSDC first public
2018-09-21T17:02:08Z
INSDC last update
2018-09-11T13:57:22Z
INSDC status
public
Submitter Id
E-MTAB-6428:Sample 13
age
34
broker name
ArrayExpress
clinical information
psoriasis area severity index 36.7
common name
human
disease
psoriasis
individual
AFOY05
organism part
blood
sample name
E-MTAB-6428:Sample 13
scientific_name
Homo sapiens
sex
male
treatment
etanercept; 50 milligram